Fine-tuning of type I IFN-signaling in microglia - implications for homeostasis, CNS autoimmunity and interferonopathies

Current Opinion in Neurobiology

Volumn 36, Issue , 2016, Pages 38-42

  Goldmann, Tobias ^a   Blank, Thomas ^a   Prinz, Marco ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DEUBIQUITINASE; GAMMA INTERFERON; INTERFERON; INTERFERON REGULATORY FACTOR 7; JANUS KINASE 1; STAT1 PROTEIN; TYPE 1 INTERFERON; UBIQUITIN SPECIFIC PROTEASE 18; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; AICARDI GOUTIERES SYNDROME; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM AUTOIMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXPERIMENTAL ALLERGIC ENCEPHALITIS; GENE; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; INTERFERON STIMULATED GENE; INTERFERONOPATHY; INTRACELLULAR SIGNALING; MICROENVIRONMENT; MICROGLIA; MOLECULAR DYNAMICS; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; CENTRAL NERVOUS SYSTEM; IMMUNOLOGY; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVOUS SYSTEM MALFORMATION; NEUROLOGIC DISEASE; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; HOMEOSTASIS; HUMANS; INTERFERON TYPE I; MICROGLIA; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVOUS SYSTEM MALFORMATIONS; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

EID: 84941985434     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2015.09.003     Document Type: Review

References (50)

1. Prinz M., Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 2014, 15:300-312.
2. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
3. Kierdorf K., Erny D., Goldmann T., Sander V., Schulz C., Perdiguero E.G., Wieghofer P., Heinrich A., Riemke P., Holscher C., et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci 2013, 16:273-280.
4. Gomez Perdiguero E., Klapproth K., Schulz C., Busch K., Azzoni E., Crozet L., Garner H., Trouillet C., de Bruijn M.F., Geissmann F., et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 2015, 518:547-551.
5. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., Prinz M., Wu B., Jacobsen S.E., Pollard J.W., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
6. Mildner A., Schmidt H., Nitsche M., Merkler D., Hanisch U.K., Mack M., Heikenwalder M., Bruck W., Priller J., Prinz M. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci 2007, 10:1544-1553.
7. Ajami B., Bennett J.L., Krieger C., Tetzlaff W., Rossi F.M. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 2007, 10:1538-1543.
8. Goldmann T., Wieghofer P., Muller P.F., Wolf Y., Varol D., Yona S., Brendecke S.M., Kierdorf K., Staszewski O., Datta M., et al. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat Neurosci 2013, 16:1618-1626.
9. Bruttger J., Karram K., Wörtge S., Regen T., Marini F., Hoppmann N., Klein M., Blank T., Yona S., Wolf Y., Mack M., Pinteaux E., Müller W., Zipp F., Binder H., Bopp T., Prinz M., Jung S., Waisman A. Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system. Immunity 2015, 43:92-106.
10. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009, 27:119-145.
11. Blank T., Prinz M. Microglia as modulators of cognition and neuropsychiatric disorders. Glia 2013, 61:62-70.
12. Goldmann T., Prinz M. Role of microglia in CNS autoimmunity. Clin Dev Immunol 2013, 2013:208093.
13. Tremblay M.E. The role of microglia at synapses in the healthy CNS: novel insights from recent imaging studies. Neuron Glia Biol 2011, 7:67-76.
14. Parkhurst C.N., Yang G., Ninan I., Savas J.N., Yates J.R., Lafaille J.J., Hempstead B.L., Littman D.R., Gan W.B. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 2013, 155:1596-1609.
15. Xue J., Schmidt S.V., Sander J., Draffehn A., Krebs W., Quester I., De Nardo D., Gohel T.D., Emde M., Schmidleithner L., et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014, 40:274-288.
16. Erny D., Hrabe de Angelis A.L., Jaitin D., Wieghofer P., Staszewski O., David E., Keren-Shaul H., Mahlakoiv T., Jakobshagen K., Buch T., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 2015, 18:965-977.
17. Costello D.A., Lynch M.A. Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-beta. Hippocampus 2013, 23:696-707.
18. Gonzalez-Navajas J.M., Lee J., David M., Raz E. Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012, 12:125-135.
19. Ivashkiv L.B., Donlin L.T. Regulation of type I interferon responses. Nat Rev Immunol 2014, 14:36-49.
20. Gough D.J., Messina N.L., Clarke C.J., Johnstone R.W., Levy D.E. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 2012, 36:166-174.
21. Schreiber G., Piehler J. The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol 2015, 36:139-149.
22. Rusinova I., Forster S., Yu S., Kannan A., Masse M., Cumming H., Chapman R., Hertzog P.J. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res 2013, 41:D1040-D1046.
23. Malakhova O.A., Kim K.I., Luo J.K., Zou W., Kumar K.G., Fuchs S.Y., Shuai K., Zhang D.E. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J 2006, 25:2358-2367.
24. Tovey M.G., Streuli M., Gresser I., Gugenheim J., Blanchard B., Guymarho J., Vignaux F., Gigou M. Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc Natl Acad Sci U S A 1987, 84:5038-5042.
25. Gough D.J., Messina N.L., Hii L., Gould J.A., Sabapathy K., Robertson A.P., Trapani J.A., Levy D.E., Hertzog P.J., Clarke C.J., et al. Functional crosstalk between type I and II interferon through the regulated expression of STAT1. PLoS Biol 2010, 8:e1000361.
26. Hwang S.Y., Hertzog P.J., Holland K.A., Sumarsono S.H., Tymms M.J., Hamilton J.A., Whitty G., Bertoncello I., Kola I. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci U S A 1995, 92:11284-11288.
27. Goldmann T., Zeller N., Raasch J., Kierdorf K., Frenzel K., Ketscher L., Basters A., Staszewski O., Brendecke S.M., Spiess A., et al. USP18 lack in microglia causes destructive interferonopathy of the mouse brain. EMBO J 2015, 34:1612-1629.
28. Baruch K., Deczkowska A., David E., Castellano J.M., Miller O., Kertser A., Berkutzki T., Barnett-Itzhaki Z., Bezalel D., Wyss-Coray T., et al. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 2014, 346:89-93.
29. Nayak D., Roth T.L., McGavern D.B. Microglia development and function. Annu Rev Immunol 2014, 32:367-402.
30. Merigan T.C., Oldstone M.B., Welsh R.M. Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature 1977, 268:67-68.
31. Nayak D., Johnson K.R., Heydari S., Roth T.L., Zinselmeyer B.H., McGavern D.B. Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system. PLoS Pathog 2013, 9:e1003395.
32. Roth-Cross J.K., Bender S.J., Weiss S.R. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol 2008, 82:9829-9838.
33. Kallfass C., Ackerman A., Lienenklaus S., Weiss S., Heimrich B., Staeheli P. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J Virol 2012, 86:11223-11230.
34. Ritchie K.J., Hahn C.S., Kim K.I., Yan M., Rosario D., Li L., de la Torre J.C., Zhang D.E. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med 2004, 10:1374-1378.
35. Ousman S.S., Wang J., Campbell I.L. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J Virol 2005, 79:7514-7527.
36. Wacher C., Muller M., Hofer M.J., Getts D.R., Zabaras R., Ousman S.S., Terenzi F., Sen G.C., King N.J., Campbell I.L. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J Virol 2007, 81:860-871.
37. Butchi N.B., Hinton D.R., Stohlman S.A., Kapil P., Fensterl V., Sen G.C., Bergmann C.C. Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages. J Virol 2014, 88:1051-1064.
38. Swanson P.A., McGavern D.B. Viral diseases of the central nervous system. Curr Opin Virol 2015, 11C:44-54.
39. Khorooshi R., Owens T. Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol 2010, 185:1258-1264.
40. Prinz M., Schmidt H., Mildner A., Knobeloch K.P., Hanisch U.K., Raasch J., Merkler D., Detje C., Gutcher I., Mages J., et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008, 28:675-686.
41. Kocur M., Schneider R., Pulm A.K., Bauer J., Kropp S., Gliem M., Ingwersen J., Goebels N., Alferink J., Prozorovski T., et al. IFNbeta secreted by microglia mediates clearance of myelin debris in CNS autoimmunity. Acta Neuropathol Commun 2015, 3:20.
42. Traugott U., Lebon P. Demonstration of alpha, beta, and gamma interferon in active chronic multiple sclerosis lesions. Ann N Y Acad Sci 1988, 540:309-311.
43. Teige I., Treschow A., Teige A., Mattsson R., Navikas V., Leanderson T., Holmdahl R., Issazadeh-Navikas S. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol 2003, 170:4776-4784.
44. Hosmane S., Tegenge M.A., Rajbhandari L., Uapinyoying P., Kumar N.G., Thakor N., Venkatesan A. Toll/interleukin-1 receptor domain-containing adapter inducing interferon-beta mediates microglial phagocytosis of degenerating axons. J Neurosci 2012, 32:7745-7757.
45. Zhang X., Bogunovic D., Payelle-Brogard B., Francois-Newton V., Speer S.D., Yuan C., Volpi S., Li Z., Sanal O., Mansouri D., et al. Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation. Nature 2015, 517:89-93.
46. Crow Y.J., Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 2009, 18:R130-R136.
47. Goutieres F. Aicardi-Goutieres syndrome. Brain Dev 2005, 27:201-206.
48. Gray F., Scaravilli F., Everall I., Chretien F., An S., Boche D., Adle-Biassette H., Wingertsmann L., Durigon M., Hurtrel B., et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996, 6:1-15.
49. Petito C.K., Adkins B., McCarthy M., Roberts B., Khamis I. CD4+ and CD8+ cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J Neurovirol 2003, 9:36-44.
50. Yona S., Kim K.W., Wolf Y., Mildner A., Varol D., Breker M., Strauss-Ayali D., Viukov S., Guilliams M., Misharin A., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.